Aminocaproic vs Dichlororibofuranosylbenzimidazole
Mechanistic comparison of Aminocaproic Acid and Dichlororibofuranosylbenzimidazole based on molecular target overlap from BindingDB and ChEMBL binding affinity data.
2
Shared Targets
18%
Jaccard Similarity
16%
IDF-Weighted Similarity
Jaccard measures raw target overlap. IDF-weighted downweights promiscuous hub targets (e.g. CYP enzymes) that bind many compounds non-specifically.
Evidence Comparison
Target Overlap
Aminocaproic and Dichlororibofuranosylbenzimidazole share 2 molecular targets based on binding affinity data from BindingDB (Kd/IC50 ≤ 10 µM) and ChEMBL. A Jaccard index of 0.182 means 18% of the combined target set is bound by both compounds. The IDF-weighted score of 0.159 accounts for non-specific binding to metabolic enzymes.
Note: High target overlap does not imply identical mechanism or therapeutic equivalence. Binding affinity, tissue distribution, bioavailability, and downstream signaling differ significantly between compounds even when they bind the same protein.
Frequently Asked Questions
Related Comparisons
Similar to Aminocaproic
Similar to Dichlororibofuranosylbenzimidazole
Dichlororibofuranosylbenzimidazole vs tetrabromobenzotriazole2 targetsDichlororibofuranosylbenzimidazole vs Dinitrochlorobenzene6 targetsDichlororibofuranosylbenzimidazole vs Desoxycorticosterone4 targetsDichlororibofuranosylbenzimidazole vs quinalizarin2 targetsDichlororibofuranosylbenzimidazole vs Melphalan5 targets